Skip to main content

MainStreet Bancshares, Inc. (MNSB) Stock Forecast 2025 - AI Price Prediction & Analysis


MainStreet Bancshares, Inc. (MNSB) AI Stock Price Forecast & Investment Analysis

MainStreet Bancshares, Inc. Stock Price Chart and Technical Analysis

Loading MainStreet Bancshares, Inc. interactive price chart and technical analysis...

MainStreet Bancshares, Inc. (MNSB) - Comprehensive Stock Analysis & Investment Research

Deep dive into MainStreet Bancshares, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about MainStreet Bancshares, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For MainStreet Bancshares, Inc.: MainStreet Bancshares, Inc. operates in the Finance sector, making it an emerging small-cap investment.

MainStreet Bancshares, Inc. (Stock Symbol: MNSB) is a leading company in the Finance sector , specifically operating within the State Commercial Banks industry.

The organization employs approximately 411 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing MainStreet Bancshares, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For MainStreet Bancshares, Inc.: With $175M in annual revenue and 32.6% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $175 million generating a 32.6% net profit margin .

Market Capitalization: $170 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 13.1% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for MainStreet Bancshares, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For MainStreet Bancshares, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for MainStreet Bancshares, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: MainStreet Bancshares, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For MainStreet Bancshares, Inc.: Strong free cash flow generation demonstrates developing operational efficiency.

MainStreet Bancshares, Inc. strategically competes in the highly dynamic State Commercial Banks marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $49 million annually, complemented by impressive 1.9% year-over-year cash flow growth.

MainStreet Bancshares, Inc. (MNSB) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for MainStreet Bancshares, Inc. stock analysis.

Loading MainStreet Bancshares, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into MainStreet Bancshares, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if MainStreet Bancshares, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For MainStreet Bancshares, Inc.: With a P/E ratio of 11.05, the market sees the stock as potentially undervalued.

P/E Ratio 11.05x
P/B Ratio 0.80x
Market Cap $170M
Dividend Yield 1.81%
EPS $-1.46
Book Value/Share $27.70
Revenue/Share $22.74
FCF/Share $1.82
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently MainStreet Bancshares, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For MainStreet Bancshares, Inc.: An ROE of 13.1% shows good shareholder value creation.

ROE 13.1%
ROA 1.1%
Net Margin 32.6%
EBT Margin 45.5%
Tax Rate 20.2%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess MainStreet Bancshares, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For MainStreet Bancshares, Inc.:

D/E Ratio 0.69x
Financial Leverage 10.91x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal MainStreet Bancshares, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For MainStreet Bancshares, Inc.: Free cash flow of $49M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $55M
Free Cash Flow $49M
Capital Spending $-6M
OCF Growth YoY 1.9%
FCF Growth YoY 0.2%
FCF/Sales 80.2%
CapEx/Sales 9.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively MainStreet Bancshares, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For MainStreet Bancshares, Inc.: An asset turnover of 0.03x suggests room for improvement in asset utilization.

Asset Turnover 0.03x
Fixed Assets Turnover 4.2x
Understanding Financial Statement Data

What these metrics mean: Key figures from MainStreet Bancshares, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For MainStreet Bancshares, Inc.: With annual revenue of $175M, MainStreet Bancshares, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $175M
Net Income $12M
SG&A Expense $41M
Balance Sheet Highlights (% Of Assets)
Cash & Short-term Investments 11%
Total Liabilities 89%
Accounts Receivable 0%
Dividend & Shareholder Information
Dividends Per Share $0.40
Payout Ratio 0.2%
Shares Outstanding 8M
Growth Metrics (YoY)
EPS Growth 7.1%

Latest MainStreet Bancshares, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting MainStreet Bancshares, Inc. (MNSB) stock price and investment outlook.

, source: Business Insider

FAIRFAX, Va., Jan. 25, 2022 /PRNewswire/ -- The Board of Directors of MainStreet Bancshares, Inc. (Nasdaq: MNSB & MNSBP), the holding company for MainStreet Bank, declared a dividend of $0.05 per ...

, source: Virginia Business

Charles “Chris” Brockett announced Friday that he’s retiring as president of MainStreet Bancshares Inc., parent company of Fairfax-based MainStreet Bank, effective March 31. Brockett has served as ...

, source: MarketWatch

Paul Thomas Haddock was the founder of Vacation Places, founded in 1981, and Azure, Inc., founded in 1984, where he held the title of President from 1984 to 2018. Mr. Haddock's current jobs include ...

MainStreet Bancshares, Inc. Competitors & Peer Analysis - Finance Sector

Comparative analysis of MainStreet Bancshares, Inc. against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ABCB Unlock Forecast - 30 Days FREE Trial $5057M 12.9x 1.3x
ACNB Unlock Forecast - 30 Days FREE Trial $471M 18.7x 1.2x
ALLY Unlock Forecast - 30 Days FREE Trial $12250M 15.3x 0.9x
AMAL Unlock Forecast - 30 Days FREE Trial $1010M 10.8x 1.3x
ASB Unlock Forecast - 30 Days FREE Trial $4359M 31.3x 0.9x
ASBA Unlock Forecast - 30 Days FREE Trial $4154M 29.8x 0.9x
ASB-PE Unlock Forecast - 30 Days FREE Trial $3661M 26.3x 0.8x
ASB-PF Unlock Forecast - 30 Days FREE Trial $3552M 25.5x 0.7x
AUB Unlock Forecast - 30 Days FREE Trial $4978M 24.4x 1.0x
AUBN Unlock Forecast - 30 Days FREE Trial $77M 12.6x 1.1x
AUB-PA Unlock Forecast - 30 Days FREE Trial $3541M 17.4x 0.7x
BAFN Unlock Forecast - 30 Days FREE Trial $37M 4.0x 0.3x
BANR Unlock Forecast - 30 Days FREE Trial $2329M 12.8x 1.3x
BCML Unlock Forecast - 30 Days FREE Trial $331M 13.7x 1.0x
BFST Unlock Forecast - 30 Days FREE Trial $745M 9.7x 0.9x
BHB Unlock Forecast - 30 Days FREE Trial $493M 12.5x 1.1x
BK Unlock Forecast - 30 Days FREE Trial $76852M 15.4x 1.8x
BK-PK Unlock Forecast - 30 Days FREE Trial $18624M 3.7x 0.4x
BKSC Unlock Forecast - 30 Days FREE Trial $87M 13.4x 2.1x
BMRC Unlock Forecast - 30 Days FREE Trial $400M 57.8x 0.9x
BMTX Unlock Forecast - 30 Days FREE Trial $58M -4.5x 2.7x
BOH Unlock Forecast - 30 Days FREE Trial $2722M 15.9x 1.6x
BOH-PA Unlock Forecast - 30 Days FREE Trial $699M 4.1x 0.4x
BOH-PB Unlock Forecast - 30 Days FREE Trial $1070M 6.3x 0.6x
BOTJ Unlock Forecast - 30 Days FREE Trial $70M 9.8x 1.0x
BPOP Unlock Forecast - 30 Days FREE Trial $8530M 11.8x 1.4x
BPOPM Unlock Forecast - 30 Days FREE Trial $1734M 2.4x 0.3x
BPOPO Unlock Forecast - 30 Days FREE Trial $1712M 2.4x 0.3x
BPRN Unlock Forecast - 30 Days FREE Trial $225M 32.9x 0.9x
BRBS Unlock Forecast - 30 Days FREE Trial $358M -1.3x 1.0x
BSRR Unlock Forecast - 30 Days FREE Trial $417M 10.3x 1.2x
BSVN Unlock Forecast - 30 Days FREE Trial $466M 10.5x 2.0x
BUSE Unlock Forecast - 30 Days FREE Trial $2194M 13.3x 1.0x
BWB Unlock Forecast - 30 Days FREE Trial $451M 11.9x 1.0x
BWBBP Unlock Forecast - 30 Days FREE Trial $549M 14.5x 1.2x
BWFG Unlock Forecast - 30 Days FREE Trial $339M 16.3x 1.2x
BY Unlock Forecast - 30 Days FREE Trial $1326M 11.1x 1.1x
CATY Unlock Forecast - 30 Days FREE Trial $3470M 11.8x 1.2x
CBAN Unlock Forecast - 30 Days FREE Trial $299M 10.8x 1.0x
CBFV Unlock Forecast - 30 Days FREE Trial $177M 15.2x 1.2x
CBSH Unlock Forecast - 30 Days FREE Trial $7597M 15.6x 3.1x
CCB Unlock Forecast - 30 Days FREE Trial $1689M 35.5x 3.7x
CCBG Unlock Forecast - 30 Days FREE Trial $742M 12.8x 1.4x
CCFN Unlock Forecast - 30 Days FREE Trial $175M 8.6x 1.0x
CCNE Unlock Forecast - 30 Days FREE Trial $545M 10.0x 0.9x
CCNEP Unlock Forecast - 30 Days FREE Trial $523M 9.6x 0.8x
CFB Unlock Forecast - 30 Days FREE Trial $0M 12.2x 0.0x
CFFI Unlock Forecast - 30 Days FREE Trial $231M 9.5x 1.0x
CFG Unlock Forecast - 30 Days FREE Trial $22718M 14.3x 0.9x
CFG-PE Unlock Forecast - 30 Days FREE Trial $8985M 5.6x 0.4x
CFG-PH Unlock Forecast - 30 Days FREE Trial $11779M 7.4x 0.5x
CHMG Unlock Forecast - 30 Days FREE Trial $251M 22.4x 1.1x
CIVB Unlock Forecast - 30 Days FREE Trial $0M 10.8x 0.0x
CNOB Unlock Forecast - 30 Days FREE Trial $1267M 33.8x 0.9x
CNOBP Unlock Forecast - 30 Days FREE Trial $1181M 31.5x 0.8x
COFS Unlock Forecast - 30 Days FREE Trial $462M 32.7x 1.1x
COLB Unlock Forecast - 30 Days FREE Trial $5457M 10.3x 1.0x
COSO Unlock Forecast - 30 Days FREE Trial $238M x 1.1x
CPF Unlock Forecast - 30 Days FREE Trial $834M 13.7x 1.5x
CSBB Unlock Forecast - 30 Days FREE Trial $120M 9.4x 1.0x
CTBI Unlock Forecast - 30 Days FREE Trial $1041M 11.4x 1.3x
CUBB Unlock Forecast - 30 Days FREE Trial $693M 4.7x 0.4x
CUBI Unlock Forecast - 30 Days FREE Trial $2212M 15.0x 1.2x
CUBI-PF Unlock Forecast - 30 Days FREE Trial $815M 5.5x 0.4x
CVBF Unlock Forecast - 30 Days FREE Trial $2817M 13.8x 1.3x
CWBC Unlock Forecast - 30 Days FREE Trial $406M 15.4x 1.1x
CZFS Unlock Forecast - 30 Days FREE Trial $295M 9.3x 0.9x
CZNC Unlock Forecast - 30 Days FREE Trial $313M 11.6x 1.1x
EBMT Unlock Forecast - 30 Days FREE Trial $140M 11.1x 0.8x
EBTC Unlock Forecast - 30 Days FREE Trial $496M 14.6x 1.3x
EFSC Unlock Forecast - 30 Days FREE Trial $2287M 11.4x 1.2x
EFSCP Unlock Forecast - 30 Days FREE Trial $771M 3.8x 0.4x
EFSI Unlock Forecast - 30 Days FREE Trial $201M 25.4x 1.1x
EGBN Unlock Forecast - 30 Days FREE Trial $602M -22.5x 0.5x
EMYB Unlock Forecast - 30 Days FREE Trial $133M 11.4x 1.2x
EQBK Unlock Forecast - 30 Days FREE Trial $738M 11.0x 1.2x
EWBC Unlock Forecast - 30 Days FREE Trial $15041M 12.6x 1.8x
FBIZ Unlock Forecast - 30 Days FREE Trial $433M 9.1x 1.3x
FBK Unlock Forecast - 30 Days FREE Trial $2483M 27.5x 1.5x
FBNC Unlock Forecast - 30 Days FREE Trial $2287M 23.5x 1.5x
FBP Unlock Forecast - 30 Days FREE Trial $3537M 11.5x 1.9x
FCBC Unlock Forecast - 30 Days FREE Trial $686M 13.7x 1.4x
FCCO Unlock Forecast - 30 Days FREE Trial $215M 12.4x 1.4x
FCNCA Unlock Forecast - 30 Days FREE Trial $26086M 10.9x 1.2x
FCNCB Unlock Forecast - 30 Days FREE Trial $22320M 9.3x 1.0x
FCNCO Unlock Forecast - 30 Days FREE Trial $307M 0.1x 0.0x
FCNCP Unlock Forecast - 30 Days FREE Trial $294M 0.1x 0.0x
FFIC Unlock Forecast - 30 Days FREE Trial $457M 19.5x 0.7x
FFIN Unlock Forecast - 30 Days FREE Trial $5173M 21.1x 3.0x
FFNW Unlock Forecast - 30 Days FREE Trial $208M 81.8x 1.3x
FFWM Unlock Forecast - 30 Days FREE Trial $494M -23.9x 0.5x
FHB Unlock Forecast - 30 Days FREE Trial $3270M 13.3x 1.2x
FIBK Unlock Forecast - 30 Days FREE Trial $3407M 14.9x 1.0x
FINW Unlock Forecast - 30 Days FREE Trial $261M 19.3x 1.4x
FITB Unlock Forecast - 30 Days FREE Trial $30660M 13.1x 1.5x
FITBI Unlock Forecast - 30 Days FREE Trial $17409M 7.5x 0.8x
FITBO Unlock Forecast - 30 Days FREE Trial $13960M 6.0x 0.7x
FITBP Unlock Forecast - 30 Days FREE Trial $16748M 7.2x 0.8x
FKYS Unlock Forecast - 30 Days FREE Trial $107M 13.8x 1.0x
FMBH Unlock Forecast - 30 Days FREE Trial $954M 11.3x 1.1x
FMBM Unlock Forecast - 30 Days FREE Trial $87M 10.3x 0.9x
FMNB Unlock Forecast - 30 Days FREE Trial $567M 11.2x 1.3x
FRAF Unlock Forecast - 30 Days FREE Trial $211M 14.5x 1.3x
FRST Unlock Forecast - 30 Days FREE Trial $294M -22.0x 0.8x
FSBC Unlock Forecast - 30 Days FREE Trial $696M 13.4x 1.7x
FUSB Unlock Forecast - 30 Days FREE Trial $76M 9.8x 0.7x
FVCB Unlock Forecast - 30 Days FREE Trial $227M 12.0x 0.9x
FXNC Unlock Forecast - 30 Days FREE Trial $212M 26.6x 1.2x
GABC Unlock Forecast - 30 Days FREE Trial $1535M 17.8x 1.4x
GBCI Unlock Forecast - 30 Days FREE Trial $5751M 26.1x 1.6x
GBFH Unlock Forecast - 30 Days FREE Trial $582M x 3.8x
GLBZ Unlock Forecast - 30 Days FREE Trial $16M 28.2x 0.8x
GNRV Unlock Forecast - 30 Days FREE Trial $7M x 0.7x
GSBC Unlock Forecast - 30 Days FREE Trial $733M 10.7x 1.2x
HBIA Unlock Forecast - 30 Days FREE Trial $749M 13.3x 1.5x
HBNC Unlock Forecast - 30 Days FREE Trial $723M 13.9x 0.9x
HBT Unlock Forecast - 30 Days FREE Trial $817M 10.6x 1.4x
HMST Unlock Forecast - 30 Days FREE Trial $262M -13.1x 0.7x
HNVR Unlock Forecast - 30 Days FREE Trial $166M 14.6x 0.8x
HOMB Unlock Forecast - 30 Days FREE Trial $5794M 15.8x 1.4x
HONE Unlock Forecast - 30 Days FREE Trial $559M 21.2x 1.0x
HTBK Unlock Forecast - 30 Days FREE Trial $635M 16.2x 0.9x
HTH Unlock Forecast - 30 Days FREE Trial $2259M 15.8x 1.0x
HTLF Unlock Forecast - 30 Days FREE Trial $0M 33.6x 0.0x
HTLFP Unlock Forecast - 30 Days FREE Trial $0M 12.6x 0.0x
HWC Unlock Forecast - 30 Days FREE Trial $5402M 13.1x 1.2x
HWCPZ Unlock Forecast - 30 Days FREE Trial $2067M 5.5x 0.5x
IBCP Unlock Forecast - 30 Days FREE Trial $1380M 21.3x 2.9x
IBOC Unlock Forecast - 30 Days FREE Trial $4382M 10.6x 1.5x
IBTX Unlock Forecast - 30 Days FREE Trial $2514M -8.0x 1.3x
INBK Unlock Forecast - 30 Days FREE Trial $215M 13.9x 0.6x
INBKZ Unlock Forecast - 30 Days FREE Trial $218M 14.1x 0.6x
INDB Unlock Forecast - 30 Days FREE Trial $2978M 15.8x 1.0x
ISBA Unlock Forecast - 30 Days FREE Trial $239M 14.7x 1.1x
ISTR Unlock Forecast - 30 Days FREE Trial $230M 10.3x 0.9x
JMSB Unlock Forecast - 30 Days FREE Trial $288M 15.2x 1.1x
LKFN Unlock Forecast - 30 Days FREE Trial $1711M 18.1x 2.4x
LNKB Unlock Forecast - 30 Days FREE Trial $274M 71.1x 1.0x
LOB Unlock Forecast - 30 Days FREE Trial $1703M 30.4x 1.6x
MBCN Unlock Forecast - 30 Days FREE Trial $246M 13.5x 1.1x
MBIN Unlock Forecast - 30 Days FREE Trial $1478M 5.8x 0.7x
MBINL Unlock Forecast - 30 Days FREE Trial $1070M 4.2x 0.5x
MBINM Unlock Forecast - 30 Days FREE Trial $1166M 4.6x 0.5x
MBINN Unlock Forecast - 30 Days FREE Trial $945M 3.7x 0.4x
MBINO Unlock Forecast - 30 Days FREE Trial $1144M 4.0x 0.6x
MBWM Unlock Forecast - 30 Days FREE Trial $786M 9.7x 1.3x
MCB Unlock Forecast - 30 Days FREE Trial $862M 12.5x 1.2x
MCBS Unlock Forecast - 30 Days FREE Trial $760M 11.5x 1.7x
MNSB Unlock Forecast - 30 Days FREE Trial $170M 11.1x 0.8x
MNSBP Unlock Forecast - 30 Days FREE Trial $183M 13.3x 0.9x
MOFG Unlock Forecast - 30 Days FREE Trial $622M -84.8x 1.1x
MPB Unlock Forecast - 30 Days FREE Trial $693M 15.7x 0.9x
MSBI Unlock Forecast - 30 Days FREE Trial $394M 7.4x 0.5x
MSBIP Unlock Forecast - 30 Days FREE Trial $514M 9.7x 0.6x
MTB Unlock Forecast - 30 Days FREE Trial $32470M 12.0x 1.1x
MTB-PH Unlock Forecast - 30 Days FREE Trial $4029M 1.5x 0.1x
MTB-PJ Unlock Forecast - 30 Days FREE Trial $4375M 1.6x 0.2x
MVBF Unlock Forecast - 30 Days FREE Trial $316M 18.5x 1.1x
MYFW Unlock Forecast - 30 Days FREE Trial $226M 19.6x 0.9x
NPB Unlock Forecast - 30 Days FREE Trial $641M x 1.1x
NTRS Unlock Forecast - 30 Days FREE Trial $25098M 14.5x 2.0x
NTRSO Unlock Forecast - 30 Days FREE Trial $4014M 2.3x 0.3x
NWFL Unlock Forecast - 30 Days FREE Trial $247M 77.9x 1.1x
NWPP Unlock Forecast - 30 Days FREE Trial $75M 8.2x 1.0x
OBK Unlock Forecast - 30 Days FREE Trial $1189M 17.0x 1.0x
OBT Unlock Forecast - 30 Days FREE Trial $357M 12.1x 1.4x
OFG Unlock Forecast - 30 Days FREE Trial $1993M 10.2x 1.5x
OPBK Unlock Forecast - 30 Days FREE Trial $212M 9.5x 1.0x
ORRF Unlock Forecast - 30 Days FREE Trial $683M 15.8x 1.3x
OSBC Unlock Forecast - 30 Days FREE Trial $836M 10.0x 1.2x
OVBC Unlock Forecast - 30 Days FREE Trial $0M 7.7x 0.0x
OVLY Unlock Forecast - 30 Days FREE Trial $245M 10.1x 1.3x
PB Unlock Forecast - 30 Days FREE Trial $6374M 12.2x 0.8x
PBHC Unlock Forecast - 30 Days FREE Trial $84M 12.4x 0.7x
PCB Unlock Forecast - 30 Days FREE Trial $313M 9.9x 0.8x
PEBK Unlock Forecast - 30 Days FREE Trial $173M 10.2x 1.2x
PEBO Unlock Forecast - 30 Days FREE Trial $1079M 10.4x 0.9x
PFBX Unlock Forecast - 30 Days FREE Trial $92M 4.7x 1.0x
PFC Unlock Forecast - 30 Days FREE Trial $1038M 13.2x 1.0x
PKBK Unlock Forecast - 30 Days FREE Trial $270M 8.7x 0.9x
PMHG Unlock Forecast - 30 Days FREE Trial $171M 21.0x 1.9x
PPBI Unlock Forecast - 30 Days FREE Trial $2376M 17.2x 0.8x
PWOD Unlock Forecast - 30 Days FREE Trial $244M 14.7x 1.5x
QCRH Unlock Forecast - 30 Days FREE Trial $1325M 11.7x 1.3x
QNBC Unlock Forecast - 30 Days FREE Trial $132M 10.3x 1.2x
RBB Unlock Forecast - 30 Days FREE Trial $354M 15.4x 0.7x
RBCAA Unlock Forecast - 30 Days FREE Trial $1511M 12.2x 1.4x
RMBI Unlock Forecast - 30 Days FREE Trial $153M 16.1x 1.2x
RNST Unlock Forecast - 30 Days FREE Trial $3677M 23.0x 1.0x
RRBI Unlock Forecast - 30 Days FREE Trial $427M 13.0x 1.3x
RVRF Unlock Forecast - 30 Days FREE Trial $272M 7.1x 1.1x
SBCF Unlock Forecast - 30 Days FREE Trial $2645M 19.1x 1.2x
SBFG Unlock Forecast - 30 Days FREE Trial $8M 10.8x 0.1x
SBSI Unlock Forecast - 30 Days FREE Trial $926M 10.8x 1.2x
SFBS Unlock Forecast - 30 Days FREE Trial $4624M 18.5x 2.7x
SFDL Unlock Forecast - 30 Days FREE Trial $98M 8.4x 0.5x
SLBK Unlock Forecast - 30 Days FREE Trial $101M 9.3x 1.0x
SPFI Unlock Forecast - 30 Days FREE Trial $687M 12.6x 1.5x
SRCE Unlock Forecast - 30 Days FREE Trial $1642M 11.6x 1.4x
SSB Unlock Forecast - 30 Days FREE Trial $10288M 17.4x 1.2x
SSBK Unlock Forecast - 30 Days FREE Trial $361M 10.6x 1.2x
STBA Unlock Forecast - 30 Days FREE Trial $1499M 12.4x 1.1x
STT Unlock Forecast - 30 Days FREE Trial $32673M 11.5x 1.2x
STT-PG Unlock Forecast - 30 Days FREE Trial $6765M 2.4x 0.3x
SYBT Unlock Forecast - 30 Days FREE Trial $2294M 17.9x 2.3x
TCBI Unlock Forecast - 30 Days FREE Trial $4015M 30.0x 1.1x
TCBIO Unlock Forecast - 30 Days FREE Trial $954M 7.1x 0.3x
TCBK Unlock Forecast - 30 Days FREE Trial $1501M 13.4x 1.2x
TECTP Unlock Forecast - 30 Days FREE Trial $74M 4.5x 0.6x
TFIN Unlock Forecast - 30 Days FREE Trial $1505M 110.5x 1.7x
TFINP Unlock Forecast - 30 Days FREE Trial $522M 38.3x 0.6x
THFF Unlock Forecast - 30 Days FREE Trial $664M 12.1x 1.2x
TMP Unlock Forecast - 30 Days FREE Trial $0M 47.6x 0.0x
TRST Unlock Forecast - 30 Days FREE Trial $752M 14.1x 1.1x
UBCP Unlock Forecast - 30 Days FREE Trial $82M 9.3x 1.4x
UBSI Unlock Forecast - 30 Days FREE Trial $5382M 13.6x 1.0x
UCB Unlock Forecast - 30 Days FREE Trial $3960M 14.5x 1.1x
UCB-PI Unlock Forecast - 30 Days FREE Trial $3033M 11.1x 0.8x
UNB Unlock Forecast - 30 Days FREE Trial $0M 16.5x 0.0x
UNTY Unlock Forecast - 30 Days FREE Trial $534M 10.6x 1.7x
USCB Unlock Forecast - 30 Days FREE Trial $0M -3.5x 0.0x
UVSP Unlock Forecast - 30 Days FREE Trial $909M 11.4x 1.0x
UWHR Unlock Forecast - 30 Days FREE Trial $84M 8.3x 1.5x
VBFC Unlock Forecast - 30 Days FREE Trial $120M 56.1x 1.6x
VBTX Unlock Forecast - 30 Days FREE Trial $3748M 32.4x 2.3x
WAL Unlock Forecast - 30 Days FREE Trial $10083M 11.9x 1.4x
WAL-PA Unlock Forecast - 30 Days FREE Trial $2587M 3.1x 0.4x
WASH Unlock Forecast - 30 Days FREE Trial $581M 13.8x 1.1x
WTBA Unlock Forecast - 30 Days FREE Trial $345M 11.9x 1.4x
WTFC Unlock Forecast - 30 Days FREE Trial $9341M 12.6x 1.3x
WTFCM Unlock Forecast - 30 Days FREE Trial $1807M 2.6x 0.3x
WTFCN Unlock Forecast - 30 Days FREE Trial $1811M 2.5x 0.3x
WTFCP Unlock Forecast - 30 Days FREE Trial $1814M 2.6x 0.3x

Frequently Asked Questions - MainStreet Bancshares, Inc. Stock Forecast

How accurate are MainStreet Bancshares, Inc. stock predictions?

Our AI model demonstrates 68% historical accuracy for MNSB predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence MainStreet Bancshares, Inc. stock price forecasts?

Our analysis considers MainStreet Bancshares, Inc.'s financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is MainStreet Bancshares, Inc. a good investment in 2025?

Based on our AI analysis, MainStreet Bancshares, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are MainStreet Bancshares, Inc. forecasts updated?

MainStreet Bancshares, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced MainStreet Bancshares, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for MainStreet Bancshares, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...